ABGX Abgenix (MM)

FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will announce financial results for the fourth quarter and full year of 2005 on Tuesday, February 21, 2006, after the close of financial markets. Following the announcement, Abgenix will host a conference call at 1:30 p.m. Pacific Time that afternoon to review the company's financial results. The live and archived webcasts of the conference call will be available on the Abgenix website, http://www.abgenix.com/. To participate in the conference call, please dial 800-591-6944 fifteen minutes before the conference begins. International callers should dial 617-614-4910. The pass code is 82136361. A telephonic replay of the call will be available by dialing 888-286-8010. International callers should dial 617-801-6888. The replay participant code is 66896648. About Abgenix Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at http://www.abgenix.com/. DATASOURCE: Abgenix, Inc. CONTACT: Greg Mann, Director of Corporate Communications & Investor Relations of Abgenix, +1-510-284-6566 Web site: http://www.abgenix.com/

Copyright